01/13/2022 | Press release | Distributed by Public on 01/13/2022 05:06
Exhibit Number |
|
1. |
(English Translation) Share Repurchase Report for the reporting month from December 1, 2021 to December 31, 2021.
|
TAKEDA PHARMACEUTICAL COMPANY LIMITED | ||
Date: January 13, 2022
|
By: | /s/ Norimasa Takeda |
Norimasa Takeda
Chief Accounting Officer and Corporate Controller
|
[Cover] | |
[Document Filed] | Share Repurchase Report |
[Applicable Law] | Article 24-6, paragraph 1 of the Financial Instruments and Exchange Act of Japan |
[Filed with] | Director, Kanto Local Finance Bureau |
[Filing Date] |
January 13, 2022
|
[Reporting period] |
From December 1, 2021 to December 31, 2021
|
[Company Name] | Takeda Pharmaceutical Company Limited |
[Title and Name of Representative] | Christophe Weber, Representative Director, President & Chief Executive Officer |
[Address of Head Office] | 1-1, Doshomachi 4-chome, Chuo-ku, Osaka |
(The above address is the registered head office location and the ordinary business
operations are conducted at the "Nearest Place of Contact")
|
|
[Telephone Number] | Not applicable |
[Name of Contact Person] | Not applicable |
[Nearest Place of Contact] | 1-1, Nihonbashi-Honcho 2-chome, Chuo-ku, Tokyo |
(Global Headquarters) | |
[Telephone Number] | +81-3-3278-2111 (Main telephone number) |
[Name of Contact Person] | Norimasa Takeda, Chief Accounting Officer & Corporate Controller, Global Finance |
[Place for public inspection] | Takeda Pharmaceutical Company Limited (Global Headquarters) |
(1-1, Nihonbashi Honcho 2-chome, Chuo-ku, Tokyo) | |
Tokyo Stock Exchange, Inc. | |
(2-1, Nihonbashi Kabutocho, Chuo-ku, Tokyo) | |
Nagoya Stock Exchange, Inc. | |
(8-20, Sakae 3-chome, Naka-ku, Nagoya) | |
Fukuoka Stock Exchange | |
(14-2, Tenjin 2-chome, Chuo-ku, Fukuoka) | |
Sapporo Stock Exchange | |
(14-1, Minamiichijonishi 5-chome, Chuo-ku, Sapporo) |
As of December 31, 2021
|
|||
Number of shares (shares) | Total repurchase amount (JPY) | ||
Status of the resolution of the Board of Directors (October 28, 2021) (Period of repurchase: from November 2, 2021 to April 29, 2022) |
35,000,000 | 100,000,000,000 | |
Repurchases during this reporting month (Date of repurchase) | (Date) | ||
ー | ー | ー | |
Total | ー | - | - |
Aggregate shares repurchased as of the end of this reporting month | 15,335,700 | 49,979,942,100 | |
Progress of share repurchase (%) | 43.82 | 49.98 |
As of December 31, 2021
|
|||
Number of shares disposed in the reporting month (shares) |
Total amount of disposition (JPY) | ||
Treasury shares disposed through offering | (Date) | ||
ー | - | - | |
Subtotal | ー | - | - |
Treasury shares canceled | (Date) | ||
ー | - | - | |
Subtotal | ー | - | - |
Treasury shares transferred upon merger, share exchange or company split |
(Date) | ||
ー | - | - | |
Subtotal | ー | - | - |
Other (upon request made by shareholders holding shares less than one unit) | (Date) | ||
December 16, 2021 | 76 | 236,512 | |
Subtotal | ー | 76 | 236,512 |
Total | 76 | 236,512 |
As of December 31, 2021
|
|
Status of treasury shares held
as of the end of the reporting month
|
Number of shares (shares) |
Total number of issued shares | 1,582,252,525 |
Number of treasury shares held | 15,511,263 |